Quantum BioPharma Accounts Payable

As of the most recent data (June 2026), QNTM shows a accounts payable of $0. That compares with $1.9M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, QNTM's accounts payable is now $0 (was $1.9M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Quantum BioPharma is outperforming or lagging.

Tracking QNTM's accounts payable over time shows whether Quantum BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.9M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Quantum BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.